References
- Wenzel SE. Asthma: Defining of persistent adult phenotypes. Lancet 2006; 368:804–813.
- Holgate S. Difficult Asthma. Dunitz: Martin, 1999.
- Wenzel SE, Szefler SJ, Leung DM, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156:737–743.
- Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154:1505–1510.
- Carroll N, Carello S, Cooke C, James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 1996; 9:709–715.
- Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A. Standardisation of spirometry. Eur Respir J 2005; 26:319 338.
- Quanjer PH, Tammeling GL, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J Suppl. 1993; 16:5 40.
- American Thoracic Society Guidelines for Methacholine and Exercise Challenge Testing, 1999. Am J Respir Crit Care Med 2000; 161:309–329.
- Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160:1001–1008.
- Michel FB, Chanez P. Asthma and corticotherapy. Presse Med 1996; 25(9):436–437.
- Nicitina LY, Petrovsky FI, Ivanchuk II, Sazonov AE. Particular qualities of apoptosis of eosiniphils in patients with severe treatment-resistant asthma. Bull Siberian Med 2005; 4:64–70.
- Hoshino M, Takahashi M, Takai Y, Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999; 104:356–63.
- Hoshino M, Nakamura Y, Sim JJ, Yamashiro Y, Uchida K, Hosaka K, Isogai S. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy 1998; 28:568–577.
- Sato E, Koyama S, Okubo Y, Kubo K, Sekiguchi M. Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. Am J Physiol 1998; 274:970–979.
- Mita Y, Dobashi K, Suzuki K, Mori M, Nakazawa T. Induction of muscarinic receptor subtypes in monocytic/macrophagic cells differentiated from EoL-1 cells. Eur J Pharmacol 1996; 297:121–127.
- Mak JC, Nishikawa M, Barnes PJ. Glucocorticosteroids increase ß2-adrenergic receptor transcription in human lung. Am J Physiol 1995; 268:L41–L46.
- Nelson HS, Chapman KR, Pyke SD, Johnson M, Pritchard JN. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol 2003; 112:29–36.
- Szefler SJ, Loung DY. Glucocorticoid-resistant asthma: Pathogenesis and clinical implications for management. Eur Respir J 1997; 10:1640–1647.